News

Smoking Doubles Risk of Spinal Damage in Ankylosing Spondylitis Patients, Study Finds

Patients with ankylosing spondylitis (AS) who smoke are twice as likely to have cumulative spinal structural damage, according to preliminary results of a systematic review study conducted by researchers at the Izmir Katip Celebi University, Turkey. This finding was the subject of an oral presentation titled “The…

Cosentyx Improved Symptoms of Ankylosing Spondylitis, Psoriatic Arthritis

Novartis recently announced that its leading drug Cosentyx (secukinumab) improves both signs and symptoms of active ankylosing spondylitis (AS), according to the results of a three-year Phase 3 extension trial called MEASURE 1. The findings were presented recently at the Annual European Congress of Rheumatology (EULAR 2017) in Madrid, Spain.